Prader-Willi syndrome
Recent articles
Oxytocin lessons from autism-linked syndromes: A chat with Christian Schaaf and Ferdinand Althammer
Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.
Oxytocin lessons from autism-linked syndromes: A chat with Christian Schaaf and Ferdinand Althammer
Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.
Dispatches from SfN 2021: Mitochondria, Rett therapy and oxytocin
These short reports from Spectrum journalists highlight some of the autism-related findings that caught our attention at the meeting this past week.
Dispatches from SfN 2021: Mitochondria, Rett therapy and oxytocin
These short reports from Spectrum journalists highlight some of the autism-related findings that caught our attention at the meeting this past week.
The push to screen newborns for rare autism-linked genetic conditions
As treatments for some autism-linked genetic conditions inch closer to the clinic, researchers are talking more urgently about screening all newborns for such conditions.
The push to screen newborns for rare autism-linked genetic conditions
As treatments for some autism-linked genetic conditions inch closer to the clinic, researchers are talking more urgently about screening all newborns for such conditions.
How to safeguard online data collection against fraud
When autism researcher Clare Harrop tried to recruit survey participants over social media, she received hundreds of fraudulent responses. But there are ways researchers can protect themselves from similar experiences.
How to safeguard online data collection against fraud
When autism researcher Clare Harrop tried to recruit survey participants over social media, she received hundreds of fraudulent responses. But there are ways researchers can protect themselves from similar experiences.
Vasopressin relieves social deficits in an autism mouse model
Mice missing a copy of MAGEL2 have trouble discerning between a familiar mouse and an unfamiliar one; treating them with the social hormone vasopressin reverses this deficit.
Vasopressin relieves social deficits in an autism mouse model
Mice missing a copy of MAGEL2 have trouble discerning between a familiar mouse and an unfamiliar one; treating them with the social hormone vasopressin reverses this deficit.
Brain-body connection may ease autistic people’s social problems
An auditory therapy may improve autistic people's emotional control and help them feel safe enough to engage with the world.
Brain-body connection may ease autistic people’s social problems
An auditory therapy may improve autistic people's emotional control and help them feel safe enough to engage with the world.
Explore more from The Transmitter
Leucovorin saga, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 June.
Leucovorin saga, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 15 June.
Models at the speed of thought: How AI coding is reshaping theoretical neuroscience
Agentic coding makes it possible to specify a neuroscience model in hours instead of months. Seven neuroscientists weigh in on what that tectonic change may bring to the field.
Models at the speed of thought: How AI coding is reshaping theoretical neuroscience
Agentic coding makes it possible to specify a neuroscience model in hours instead of months. Seven neuroscientists weigh in on what that tectonic change may bring to the field.
Writing science that humans and machines can read
Large language models are now routinely used to search, summarize and synthesize the literature at scales impossible for any individual researcher—yet scientific publishing has not adapted to that reality.
Writing science that humans and machines can read
Large language models are now routinely used to search, summarize and synthesize the literature at scales impossible for any individual researcher—yet scientific publishing has not adapted to that reality.